-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, McPharmaceutical-B (02335.HK) announced that the pre-clinical and phase I clinical data of MT200605, an injectable neuroprotective candidate for the treatment of acute ischemic stroke (AIS) independently developed by the Group, has been accepted to present an oral report at the 18th World Stroke Congress (WSC 2026) in 2026.

Zhitongcaijing·08/10/2026 15:01:10
Listen to the news
Zhitong Finance App News, McPharmaceutical-B (02335.HK) announced that the pre-clinical and phase I clinical data of MT200605, an injectable neuroprotective candidate for the treatment of acute ischemic stroke (AIS) independently developed by the Group, has been accepted to present an oral report at the 18th World Stroke Congress (WSC 2026) in 2026.